Researchers, Advocates Encouraged By PrEP As HIV Prevention Tool, Say Health Delivery Systems Must Be Bolstered

Devex: Barriers to PrEP: Rollout of this HIV prevention tool is hitting bumps
“…Pre-exposure prophylaxis, or PrEP, is the use of antiretroviral medication to prevent the acquisition of HIV infection by uninfected people. In 2014, the World Health Organization recommended offering PrEP to men who have sex with men — known as MSM — and in September broadened its recommendation to include all people at substantial risk of HIV infection as an additional prevention choice. … Keletso Makofane from the Global Forum on MSM and HIV said that while the prevention tool was encouraging, it would have no impact unless the health care delivery systems responsible for delivering PrEP were fixed. Staff shortages, frequent stockouts, treatment oversights, and stigma within clinics and the community were some of the issues he listed…” (Cousins, 7/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.